Royal Bank Of Canada Teva Pharmaceutical Industries LTD Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Royal Bank Of Canada holds 1,004,553 shares of TEVA stock, worth $17.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,004,553

Previous 514,798 95.14%

Holding current value

$17.1 Million

Previous $8.37 Million 116.4%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$15.81 - $18.96 $7.74 Million - $9.29 Million	489,755 Added 95.14%	1,004,553 $18.1 Million
Q2 2024 Nov 06, 2024	SELL	$12.78 - $17.4 $177,514 - $241,685	-13,890 Reduced 2.63%	514,798 $8.37 Million
Q2 2024 Aug 14, 2024	BUY	$12.78 - $17.4 $1.51 Million - $2.06 Million	118,140 Added 28.78%	528,688 $8.59 Million
Q1 2024 Nov 05, 2024	SELL	$10.67 - $14.43 $1.41 Million - $1.91 Million	-132,606 Reduced 25.08%	396,082 $5.59 Million
Q1 2024 May 15, 2024	BUY	$10.67 - $14.43 $943,836 - $1.28 Million	88,457 Added 27.46%	410,548 $5.79 Million
Q4 2023 Feb 14, 2024	SELL	$8.12 - $10.63 $18,676 - $24,449	-2,300 Reduced 0.71%	322,091 $3.36 Million
Q3 2023 Nov 14, 2023	SELL	$7.48 - $10.7 $39,494 - $56,495	-5,280 Reduced 1.6%	324,391 $3.31 Million
Q2 2023 Aug 14, 2023	BUY	$7.2 - $9.47 $450,158 - $592,083	62,522 Added 23.4%	329,671 $2.48 Million
Q1 2023 May 15, 2023	BUY	$8.36 - $11.37 $84,745 - $115,257	10,137 Added 3.94%	267,149 $2.36 Million
Q4 2022 Feb 14, 2023	SELL	$7.95 - $9.48 $1.61 Million - $1.92 Million	-202,725 Reduced 44.1%	257,012 $2.34 Million
Q3 2022 Nov 14, 2022	BUY	$6.86 - $11.95 $436,021 - $759,542	63,560 Added 16.04%	459,737 $3.71 Million
Q2 2022 Aug 15, 2022	SELL	$7.38 - $10.4 $4.05 Million - $5.7 Million	-548,244 Reduced 58.05%	396,177 $2.98 Million
Q1 2022 May 16, 2022	SELL	$7.33 - $9.39 $1.16 Million - $1.49 Million	-158,744 Reduced 14.39%	944,421 $8.87 Million
Q4 2021 Feb 14, 2022	BUY	$7.9 - $10.19 $975,578 - $1.26 Million	123,491 Added 12.61%	1,103,165 $8.84 Million
Q3 2021 Nov 15, 2021	BUY	$8.38 - $10.18 $2.04 Million - $2.48 Million	243,822 Added 33.13%	979,674 $9.54 Million
Q2 2021 Aug 16, 2021	BUY	$9.9 - $11.56 $7.28 Million - $8.51 Million	735,852 New	735,852 $7.29 Million

Others Institutions Holding TEVA

# of Institutions

638

Shares Held

580M

Call Options Held

19.6M

Put Options Held

6.77M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $18.9B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Teva Pharmaceutical Industries LTD Transaction History